AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2017
Jun 20, 2017
33341_dirs_2017-06-20_21a212f7-ade8-4aeb-a727-4cf3b673f262.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCIA/B)
CIK: 0000070487
Period of Report: 2017-06-16
Reporting Person: NUNNELLY JOHN N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-16 | Class A Common Stock | M | 9106 | $7.78 | Acquired | 37806 | Direct |
| 2017-06-16 | Class A Common Stock | F | 2576 | $27.50 | Disposed | 35230 | Direct |
| 2017-06-16 | Class A Common Stock | S | 6530 | $27.543 | Disposed | 28700 | Direct |
| 2017-06-19 | Class A Common Stock | M | 6472 | $7.78 | Acquired | 35172 | Direct |
| 2017-06-19 | Class A Common Stock | F | 1834 | $27.45 | Disposed | 33338 | Direct |
| 2017-06-19 | Class A Common Stock | S | 4638 | $27.50 | Disposed | 28700 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-16 | Director Stock Option (Right to Buy) | $7.78 | M | 9106 | Disposed | 2019-05-08 | Class A Common Stock (9106) | Direct |
| 2017-06-19 | Director Stock Option (Right to Buy) | $7.78 | M | 6472 | Disposed | 2019-05-08 | Class A Common Stock (6472) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 3900 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $7.61 | 2020-05-07 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $9.73 | 2021-05-06 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $13.81 | 2022-05-11 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $16.89 | 2023-05-09 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $14.95 | 2024-05-08 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $14.21 | 2025-05-07 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $14.19 | 2026-05-11 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $24.35 | 2027-05-09 | Class A Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $16.8 | 2020-05-07 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $19.98 | 2021-05-06 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $26.1 | 2022-05-11 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $30.72 | 2023-05-09 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $43.91 | 2024-05-08 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $34.50 | 2025-05-07 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $37.78 | 2026-05-11 | Class B Common Stock (6000) | 6000 | Direct |
| Director Stock Option (Right to Buy) | $44.47 | 2027-05-09 | Class B Common Stock (6000) | 6000 | Direct |
Footnotes
F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $27.50 to $27.65. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
More from NATIONAL RESEARCH CORP
Regulatory Filings
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20